# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
ONMD: 66% | OneMedNet shares are trading higher after the company announced that it has entered into a non-exclusive three-year...
As of the data cut-off date, CAN-2409 treatment in NSCLC continued to exhibit a favorable safety and tolerability profile